Featured Research

from universities, journals, and other organizations

Analysis Of Spanish Flu Cases In 1918-1920 Suggests Transfusions Might Help In Bird Flu Pandemic

Date:
August 30, 2006
Source:
American College of Physicians
Summary:
Transfusions with blood products taken from people who had recovered from Spanish influenza may have reduced risk for death and improved symptoms of hospitalized patients who contracted Spanish influenza complicated by pneumonia. Early treatment was superior to later treatment. Researchers studied medical literature published shortly after the 1918 Spanish flu pandemic and found eight relevant studies.

Transfusions with blood products taken from people who had recovered from Spanish influenza may have reduced risk for death and improved symptoms of hospitalized patients who contracted Spanish influenza complicated by pneumonia. Early treatment was superior to later treatment.

Researchers studied medical literature published shortly after the 1918 Spanish flu pandemic and found eight relevant studies.

Similar transfusions might be useful in treating victims of a bird flu pandemic, especially in light of the problems with existing vaccines and treatments, say authors of the Spanish flu study. They say that a single recovering bird-flu patient could donate "a weekly volume of plasma sufficient to treat multiple patients with H5N1 influenza."

The article "Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?" will be published in the Oct. 17, 2006, print edition of Annals of Internal Medicine.

Spanish flu (H1N1) and bird flu (H5N1) are subtypes of influenza A virus. The Spanish flu pandemic in 1918 to 1920 killed between 20 million and 100 million people worldwide.

The World Health Organization (WHO) says that a bird-flu pandemic is a serious possibility today. As of August 24, 2006, 241 cases of confirmed avian flu A/(H5N1) have been reported to WHO, resulting in 141 deaths.

WHO says H5N1 virus is widespread in birds, particularly poultry which seems to be the source of the Asian infections. Widespread prevalence of the virus in birds increases the chance of transmission from bird to human. When human cases become transmissible from human to human, a flu epidemic begins. If it is virulent, it will spread fast. If there are no effective antiviral drugs available, it will spread faster.

WHO says the world is not prepared to handle a bird-flu pandemic. Vaccines to prevent the particular flu strain of the pandemic will take time to manufacture and distribute after the first outbreaks.

Current recommended treatment is hospitalization and treatment with an antiviral drug, but studies of bird flu outbreaks in Asia have found that 30 percent to 80 percent of patients treated this way have died.

And WHO says the manufacturer of the most currently used drug (oseltamavir) does not have capacity to fill existing orders immediately. During an epidemic, antiviral agents, antibiotics and other medications may be rationed or not available to the most severely ill patients.

The WHO says that most developing countries will have no access to vaccines and antiviral drugs throughout a pandemic.

So the authors of the Spanish flu study believe blood product therapy has promising implications for the current situation.

The study has important limitations: the number of studies was small, the number of patients was small, and assignment to treatment or controls was not random, blinded or placebo-controlled; dosages and definitions were not standardized; disruptions caused by World War I probably affected medical personnel available to record data as well as exacerbated the spread of the disease; and wartime censorship may have affected publication of existing research. (The name "Spanish flu" came from the fact that Spain was not a partner in World War I and its press was freer to report details of the pandemic than press in combatant countries who did not want reveal information about deaths and sickness to enemies.)

The authors call for convening a body of experts "to consider H5N1 plasma therapy and to make recommendations for a research strategy and possibly treatment guidelines if therapy is required before the research is completed."

John J. Treanor, MD, says, in an accompanying editorial, that the idea that "passive serotherapy" might be useful in treating H5N1 virus infection has precedence in other viral diseases such as chicken pox, rabies and hepatitis A and B.

Treanor, of the infectious disease division of the University of Rochester Medical Center, identifies concerns with logistics, such as the ability to obtain, classify and prepare the blood materials in the midst of an outbreak, and missing information, such as whether people who recover from H5N1 infection actually develop high levels of an antibody or what is the most effective level of antibody or appropriate dose of plasma needed to achieve success in infected patients.

"Although many logistical hurdles exist, controlled clinical studies done now will probably pay a considerable dividend when the pandemic begins," Treanor says. "We can, should, and must explore these issues about serotherapy now, in advance of the pandemic."


Story Source:

The above story is based on materials provided by American College of Physicians. Note: Materials may be edited for content and length.


Cite This Page:

American College of Physicians. "Analysis Of Spanish Flu Cases In 1918-1920 Suggests Transfusions Might Help In Bird Flu Pandemic." ScienceDaily. ScienceDaily, 30 August 2006. <www.sciencedaily.com/releases/2006/08/060830075728.htm>.
American College of Physicians. (2006, August 30). Analysis Of Spanish Flu Cases In 1918-1920 Suggests Transfusions Might Help In Bird Flu Pandemic. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2006/08/060830075728.htm
American College of Physicians. "Analysis Of Spanish Flu Cases In 1918-1920 Suggests Transfusions Might Help In Bird Flu Pandemic." ScienceDaily. www.sciencedaily.com/releases/2006/08/060830075728.htm (accessed July 22, 2014).

Share This




More Plants & Animals News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Michigan Plant's Goal: Flower and Die

Michigan Plant's Goal: Flower and Die

AP (July 22, 2014) An 80-year-old agave plant, which is blooming for the first and only time at a University of Michigan conservatory, will die when it's done (July 22) Video provided by AP
Powered by NewsLook.com
San Diego Zoo Welcomes New, Rare Rhino Calf

San Diego Zoo Welcomes New, Rare Rhino Calf

Reuters - US Online Video (July 21, 2014) An endangered black rhino baby is the newest resident at the San Diego Zoo. Sasha Salama reports. Video provided by Reuters
Powered by NewsLook.com
Shark Sightings a Big Catch for Cape Tourism

Shark Sightings a Big Catch for Cape Tourism

AP (July 21, 2014) A rise in shark sightings along the shores of Chatham, Massachusetts is driving a surge of eager vacationers to the beach town looking to catch a glimpse of a great white. (July 21) Video provided by AP
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins